| B细胞非霍奇金淋巴瘤靶向药物治疗研究进展 |
| |
| 引用本文： | 马晓松,汪步海,梁一晨,韩 枫,吴越超.B细胞非霍奇金淋巴瘤靶向药物治疗研究进展[J].现代肿瘤医学,2022,0(12):2272-2275. |
| |
| 作者姓名： | 马晓松 汪步海 梁一晨 韩 枫 吴越超 |
| |
| 作者单位： | 1.大连医科大学，辽宁 大连 116000;2.江苏省苏北人民医院肿瘤研究所，江苏 扬州 225000 |
| |
| 基金项目： | 江苏省扬州市重点研发项目（编号:YZ2019057） |
| |
| 摘 要： | B细胞非霍奇金淋巴瘤(B-cell non-Hodgkin's lymphoma,B-NHLs)代表了一组异质性的来源于血液系统的恶性肿瘤,目前针对B-NHLs一线治疗方案仍是经典标准R-CHOP方案。近几年，靶向阻断分子或细胞机制在淋巴瘤中具有改变临床实践的意义，靶向治疗手段已成为了越来越重要的预测和肿瘤治疗方案，本文就近年来B-NHLs靶向治疗新进展作一综述。
|
| 关 键 词： | 淋巴瘤 B细胞非霍奇金淋巴瘤 靶向治疗药物 治疗 |
Advances in targeted drug therapy for B-cell non-Hodgkin' s lymphoma |
| |
| MA Xiaosong,WANG Buhai,LIANG Yichen,HAN Feng,WU Yuechao.Advances in targeted drug therapy for B-cell non-Hodgkin' s lymphoma[J].Journal of Modern Oncology,2022,0(12):2272-2275. |
| |
| Authors: | MA Xiaosong WANG Buhai LIANG Yichen HAN Feng WU Yuechao |
| |
| Institution: | 1.Dalian Medical University,Liaoning Dalian 116000,China;2.Cancer Institute of North Jiangsu People's Hospital,Jiangsu Yangzhou 225000,China. |
| |
| Abstract: | B-cell non-Hodgkin lymphoma (B-NHLs) represents a group of heterogeneous malignancies derived from the blood system,and the current first-line treatment regimen for B-NHLs is still the classic standard R-CHOP regimen.In recent years,targeted blocking of molecular or cellular mechanisms has the significance of changing clinical practice in lymphoma,and targeted therapy has become an increasingly important prediction and tumor treatment regimen.This paper will review the recent progress of B-NHLs targeted therapy. |
| |
| Keywords: | lymphoma B-cells non-Hodgkin's lymphoma targeted therapy drugs treatment |
|
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
| 点击此处可从《现代肿瘤医学》下载免费的PDF全文 |
